SEC FORM 3

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Duval Santiago Arias

(Last)

(First)

(Middle)

C/O INGERSOLL RAND INC.,

525 HARBOUR PLACE DRIVE, SUITE 600

(Street)

DAVIDSON

28036

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/07/2023

3. Issuer Name and Ticker or Trading Symbol
Ingersoll Rand Inc. [ IR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	⁽¹⁾	⁽¹⁾	Common Stock	863	⁽¹⁾	D
Restricted Stock Units	⁽²⁾	⁽²⁾	Common Stock	636	⁽²⁾	D
Restricted Stock Units	⁽³⁾	⁽³⁾	Common Stock	548	⁽³⁾	D
Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Common Stock	483	⁽⁴⁾	D
Stock Options (Right to Buy)	⁽⁵⁾	02/23/2033	Common Stock	2,009	57.89	D
Stock Options (Right to Buy)	⁽⁶⁾	02/22/2032	Common Stock	2,122	53.09	D
Stock Options (Right to Buy)	⁽⁷⁾	02/23/2031	Common Stock	2,779	45.58	D
Stock Options (Right to Buy)	⁽⁸⁾	03/25/2030	Common Stock	3,741	23.28	D
Stock Options (Right to Buy)	⁽⁹⁾	04/25/2029	Common Stock	638	27.78	D
Stock Options (Right to Buy)	⁽¹⁰⁾	02/21/2029	Common Stock	1,139	27.05	D

Explanation of Responses:

1. Represents unvested restricted stock units, which will vest in four equal annual installments on February 23, 2024, 2025, 2026 and 2027, and upon vesting, will each be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof.

2. Represents unvested restricted stock units, which will vest in three remaining equal annual installments on February 22, 2024, 2025 and 2026, and upon vesting, will each be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof.

3. Represents unvested restricted stock units granted, which will vest in two remaining equal annual installments on February 23, 2024 and 2025, and upon vesting, will each be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof.

4. Represents unvested restricted stock units, which will vest on March 25, 2024, and upon vesting, will each be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof.

5. Represents stock options, which will vest in four equal annual installments on February 23, 2024, 2025, 2026 and 2027.

6. Represents stock options, of which 1,592 are unvested and will vest in three remaining equal annual installments on February 22, 2024, 2025 and 2026.

7. Represents stock options, of which 1,390 are unvested and will vest in two remaining equal annual installments on February 23, 2024 and 2025.

8. Represents stock options, of which 1,247 are unvested and will vest on March 25, 2024.

9. These stock options are fully vested and exercisable.

10. These stock options are fully vested and exercisable.

Remarks:

Title: Vice President and General Manager, Precision & Science Technologies Exhibit 24 - Power of Attorney

	/s/ Andrew Schiesl, Attorney-in-Fact	09/18/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

SEC Form 3 filed by new insider Duval Santiago Arias